4//SEC Filing
ABBE CHARLES J 4
Accession 0001227025-20-000166
CIK 0001227025other
Filed
Nov 3, 7:00 PM ET
Accepted
Nov 4, 8:30 PM ET
Size
13.8 KB
Accession
0001227025-20-000166
Insider Transaction Report
Form 4
ABBE CHARLES J
Director
Transactions
- Exercise/Conversion
Common Stock
2020-11-02$6.78/sh+12,486$84,655→ 122,414 total - Exercise/Conversion
Common Stock
2020-11-02$5.74/sh+7,421$42,597→ 129,835 total - Exercise/Conversion
Common Stock
2020-11-02$4.33/sh+14,056$60,862→ 109,928 total - Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2020-11-02−14,056→ 0 totalExercise: $4.33Exp: 2029-06-03→ Common Stock (14,056 underlying) - Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2020-11-02−7,421→ 0 totalExercise: $5.74Exp: 2022-10-02→ Common Stock (7,421 underlying) - Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2020-11-02−12,486→ 0 totalExercise: $6.78Exp: 2028-06-04→ Common Stock (12,486 underlying)
Footnotes (3)
- [F1]Represents a cash exercise.
- [F2]This option shall vest ratably at a rate of 1/12th of the total number of shares granted on each monthly anniversary of the grant date, so long as the Reporting Person remains a member of the Board of Directors of the Company.
- [F3]The shares subject to the option will vest in forty-eight (48) equal monthly installments from the grant date, such that the option is fully vested on the fourth anniversary of the date of the grant, subject to the Reporting Person's Continuous Service (as defined in the Issuer's 2010 Equity Incentive Plan).
Documents
Issuer
NEOPHOTONICS CORP
CIK 0001227025
Entity typeother
Related Parties
1- filerCIK 0001037108
Filing Metadata
- Form type
- 4
- Filed
- Nov 3, 7:00 PM ET
- Accepted
- Nov 4, 8:30 PM ET
- Size
- 13.8 KB